New cell lines, heightened concerns about product safety, emerging biosimilars, and a vaccine industry shifting to cell culture–based production all point to a need for forward-thinking technology and product platforms.

Leveraging core expertise in cell culture development, downstream purification, and rapid molecular-based contaminant testing, the Life Technologies Bioproduction group is providing workflow solutions today to a biopharmaceutical industry at the cusp of transforming traditional disease treatment.

To obtain our schedule of upcoming events, click here.

There are no events available at this time.